We are live on ! Find out more

1,062 hedge funds and large institutions have $68.3B invested in Amgen in 2013 Q3 according to their latest regulatory filings, with 95 funds opening new positions, 372 increasing their positions, 430 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 95 | Existing positions closed: 52

19% more funds holding in top 10

Funds holding in top 10: 4857 (+9)

14% more capital invested

Capital invested by funds: $59.9B → $68.3B (+$8.37B)

3% more funds holding

Funds holding: 1,0321,062 (+30)

13% less repeat investments, than reductions

Existing positions increased: 372 | Existing positions reduced: 430

17% less call options, than puts

Call options by funds: $780M | Put options by funds: $936M

Holders
1,062
Holders Change
+30
Holders Change %
+2.91%
% of All Funds
34.42%
Holding in Top 10
57
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+18.75%
% of All Funds
1.85%
New
95
Increased
372
Reduced
430
Closed
52
Calls
$780M
Puts
$936M
Net Calls
-$156M
Net Calls Change
+$150K
Name Holding Trade Value Shares
Change
Change in
Stake
Capital Research Global Investors
1
Capital Research Global Investors
California
$7.57B +$58.6M +540,100 +0.8%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$5.72B -$261M -2,405,932 -4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.07B +$82M +755,914 +2%
Primecap Management
4
Primecap Management
California
$4.01B -$167M -1,536,766 -4%
State Street
5
State Street
Massachusetts
$3.47B -$35.3M -325,197 -1%
BIT
6
BlackRock Institutional Trust
California
$2.36B -$64.3M -593,000 -3%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$2.29B +$38.8M +357,846 +2%
Invesco
8
Invesco
Georgia
$1.88B -$16.4M -151,319 -0.9%
Franklin Resources
9
Franklin Resources
California
$1.3B +$134M +1,231,416 +12%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$1.28B +$160M +1,471,385 +15%
Northern Trust
11
Northern Trust
Illinois
$1.26B -$50.5M -466,096 -4%
BFA
12
BlackRock Fund Advisors
California
$1.15B +$56.6M +522,041 +5%
ClearBridge Investments
13
ClearBridge Investments
New York
$858M -$412K -3,803 -0%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$804M +$85.3M +786,675 +12%
BG
15
BlackRock Group
United Kingdom
$710M +$35.2M +324,504 +5%
Norges Bank
16
Norges Bank
Norway
$693M -$6.04M -55,668 -0.9%
TCIM
17
TIAA CREF Investment Management
New York
$661M -$106M -977,146 -14%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$613M +$17.3M +159,942 +3%
Ameriprise
19
Ameriprise
Minnesota
$587M -$5.12M -47,212 -0.9%
Boston Partners
20
Boston Partners
Massachusetts
$572M -$10.1M -93,067 -2%
Deutsche Bank
21
Deutsche Bank
Germany
$543M +$61.5M +567,617 +13%
Winslow Capital Management
22
Winslow Capital Management
Minnesota
$521M -$9.02M -83,146 -2%
JHIU
23
Janus Henderson Investors US
Colorado
$509M -$69.7M -642,842 -12%
LSV Asset Management
24
LSV Asset Management
Illinois
$494M -$84.8M -781,680 -15%
Capital International Investors
25
Capital International Investors
California
$471M -$30.7M -283,400 -6%

AMGN Hedge Fund Activity: Q3 2013 in Review

1,062 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2013, worth a combined $68.3B — up 14% from $59.9B a quarter earlier.

Buyers outnumbered sellers: 95 funds opened new AMGN positions and 52 closed out — a net gain of 43 holders — while 372 added to existing stakes and 430 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $176M. The largest seller was Fidelity Investments, cutting an estimated $261M.

  • 1,062 institutional investors held Amgen (AMGN) as of Q3 2013, up from 1,032 in Q2 2013.
  • Funds reported $68.3B of Amgen stock for Q3 2013, up 14% quarter-over-quarter.
  • 95 funds opened new Amgen positions in Q3 2013 and 52 closed out, a net change of +43 holders.
  • The largest Amgen buyer in Q3 2013 was Adage Capital Partners, an estimated $176M added.
  • The largest Amgen seller in Q3 2013 was Fidelity Investments, an estimated $261M sold.

Based on aggregated 13F filings for Q3 2013.